BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23192326)

  • 1. Association between killer cell immunoglobulin-like receptor (KIR) polymorphisms and systemic lupus erythematosus (SLE) in populations: A PRISMA-compliant meta-analysis.
    Liang HL; Ma SJ; Tan HZ
    Medicine (Baltimore); 2017 Mar; 96(10):e6166. PubMed ID: 28272205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of toll-like receptor polymorphisms with systemic lupus erythematosus: A meta-analysis.
    Lee YH; Song GG
    Heliyon; 2024 Mar; 10(6):e27987. PubMed ID: 38509975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AXIN2 rs2240308 polymorphism contributes to increased cancer risk: evidence based on a meta-analysis.
    Wu Z; Sun Y; Tang S; Liu C; Zhu S; Wei L; Xu H
    Cancer Cell Int; 2015; 15():68. PubMed ID: 26161041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FGFR2 Variant rs13387042 is Associated With Breast Cancer Risk: A Meta-Analysis and Systematic Review.
    Pan W; Cheng H; Zhang J; Yang Z; Lin M
    Clin Breast Cancer; 2024 Mar; ():. PubMed ID: 38641470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of IL-6-572 polymorphism with sepsis: An updated meta-analysis.
    Hou F; Gao J; Zhang L; Liu C
    Cytokine; 2024 Jul; 179():156597. PubMed ID: 38643631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of developing lung cancer in Asian patients carrying the TERT rs2736098 G>A polymorphism: evidence from 3,354 cases and 3,518 controls.
    Yang Z; Zhang X; Fang S; Tan Y; Yan H; Gu W; Wang J
    Onco Targets Ther; 2015; 8():2757-65. PubMed ID: 26491349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consolidating data on the association of IL-6 and IL-10 polymorphisms with the development of glaucoma: a meta-analysis.
    Golshan-Tafti A; Bahrami M; Mohsenzadeh-Yazdi R; Dastgheib SA; Aghasipour M; Shiri A; Alijanpour K; Asadian F; Aghili K; Manzourolhojeh M; Neamatzadeh H
    Ophthalmic Genet; 2024 Apr; ():1-11. PubMed ID: 38602069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of the prothrombin A19911G single-nucleotide polymorphism and the risk of venous thromboembolism: A systematic review and meta-analysis.
    Xiang K; Xu H; Zhang Y; Leng Q; Zhang F
    Phlebology; 2024 Apr; ():2683555241247095. PubMed ID: 38616379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rs1991517 polymorphism is a genetic risk factor for congenital hypothyroidism.
    Kollati Y; Akella RRD; Naushad SM; Thalla M; Reddy GB; Dirisala VR
    3 Biotech; 2020 Jun; 10(6):285. PubMed ID: 32550104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between polymorphism of
    Lu F; Gao G; Zhang H; Zhang W
    Nucleosides Nucleotides Nucleic Acids; 2024 Mar; ():1-17. PubMed ID: 38555596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 6 and 10 Serum Levels and Genetic Polymorphisms in Children with Down Syndrome.
    Mattos MF; Biselli-Chicote PM; Biselli JM; da Silva Assembleia TL; Goloni-Bertollo EM; Pavarino ÉC
    Mediators Inflamm; 2018; 2018():6539548. PubMed ID: 30186038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
    Leonard D; Svenungsson E; Dahlqvist J; Alexsson A; Ärlestig L; Taylor KE; Sandling JK; Bengtsson C; Frodlund M; Jönsen A; Eketjäll S; Jensen-Urstad K; Gunnarsson I; Sjöwall C; Bengtsson AA; Eloranta ML; Syvänen AC; Rantapää-Dahlqvist S; Criswell LA; Rönnblom L
    Ann Rheum Dis; 2018 Jul; 77(7):1063-1069. PubMed ID: 29514802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic patterns of interleukin 10 expression--a review.
    Trifunović J; Miller L; Debeljak Ž; Horvat V
    Biochem Med (Zagreb); 2015; 25(1):36-48. PubMed ID: 25672465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of interleukin-10 promoter haplotypes with disease susceptibility and IL-10 levels in Mexican patients with systemic lupus erythematosus.
    Palafox-Sánchez CA; Oregon-Romero E; Salazar-Camarena DC; Valle YM; Machado-Contreras JR; Cruz A; Orozco-López M; Orozco-Barocio G; Vázquez-Del Mercado M; Muñoz-Valle JF
    Clin Exp Med; 2015 Nov; 15(4):439-46. PubMed ID: 25253090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis.
    Liu P; Song J; Su H; Li L; Lu N; Yang R; Peng Z
    PLoS One; 2013; 8(7):e69547. PubMed ID: 23936042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10RB rs2834167 (A/G) polymorphism is associated with the susceptibility to systemic lupus erythematosus: evidence from a study in Chinese Han population.
    Peng H; Liu CY; Zhou M; Wen PF; Zhang M; Qiu LJ; Ni J; Liang Y; Pan HF; Ye DQ
    Inflammation; 2013 Dec; 36(6):1218-24. PubMed ID: 23749100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.
    Peng H; Wang W; Zhou M; Li R; Pan HF; Ye DQ
    Clin Rheumatol; 2013 Sep; 32(9):1255-66. PubMed ID: 23708831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the interleukin-10 gene polymorphism (-1082A/G) with systemic lupus erythematosus: a meta-analysis.
    Zhou M; Ding L; Peng H; Wang B; Huang F; Xu WD; Li JH; Ye XR; Pan HF; Ye DQ
    Lupus; 2013 Feb; 22(2):128-35. PubMed ID: 23192326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
    Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
    Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.